Cholesterol news and cholesterol widget

Using the VAP Cholesterol Test from Atherotech, Inc., investigators led by Michel Farnier M.D., of Point Medical, Rond Point de la Nation, Dijon, France, have reported beneficial changes in lipoprotein subclasses and LDL particle size using combination therapy. The information could be helpful to physicians because of the known association between abnormal lipoprotein subfractions and increased cardiovascular risk in patients with mixed hyperlipidemia.

The cholesterol medication Crestor, manufactured by AstraZeneca, can reduce by about half the risk for heart attack, stroke and death among patients who do not have high cholesterol levels but tested positive for high levels of a protein linked with increased risk for heart attack, according to a study presented Sunday at the annual meeting of the

Reuters - Abbott Laboratories Inc's experimental drug TriLipix was able to significantly improve cholesterol and triglyceride levels in patients for another year following earlier three-month trials, researchers said on Tuesday.

HealthDay - TUESDAY, Nov. 11 (HealthDay News) -- High levels of lipoprotein particles may increase the risk of high blood pressure in women who currently have normal blood pressure.

Reuters - An obese child's arteries may be just as clogged as the arteries of someone who is middle-aged, researchers said on Tuesday.

Reuters - For people keeping track of their blood fats, triglycerides may be the new lipid to watch, researchers said on Tuesday.

Reuters - High levels of triglycerides, a fatty molecule found in the blood, detected while a person is not fasting, are associated with an increased risk of stroke, according to analysis of data from the Copenhagen City Heart Study.

Use of the cholesterol medication Crestor, manufactured by AstraZeneca, to prevent cardiovascular events in patients who do not have high cholesterol levels but have high levels of C-reactive protein would increase U.S. health care costs by $10 billion annually, according to an analysis released on Monday, USA Today reports (Sternberg, USA Today, 11/10). read more